FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017013928> ?p ?o ?g. }

• W2017013928 endingPage "1699" @default.
• W2017013928 startingPage "1691" @default.
• W2017013928 abstract "Current anticancer therapy is a delicate balance between elimination of malignant cells and harmful side effects for the host. In this study, we used a tumor-homing peptide to engineer anti-CD40 agonist antibodies and recombinant IL-2 such that they were selectively delivered into spontaneously arising tumors in a transgenic mouse model of islet cell carcinogenesis. Intravenous injection of these agents, either separately or together, led to accumulation in the vicinity of tumor neovessels without toxic side effects. Although both molecules are critical for adaptive immunity, the most profound effects were seen in endothelial cells. Combined, local anti-CD40 and IL-2 therapy reduced tumor vascularity and significantly delayed tumor growth in mice. Remarkably, tumor-bearing mice remained disease-free long-term when targeted anti-CD40 and IL-2 were combined with transfers of preactivated antitumor immune cells. In this therapeutic setting, triggering of CD40 on endothelial cells induced an inflammatory response of the vessel wall and facilitated effector cell accumulation in the tumor parenchyma while IL-2 promoted antigen-specific immune cell persistence. We believe this is a novel and highly effective anticancer approach, whereby tumor stroma is conditioned for enhanced immune cell entry and survival, facilitating immune-mediated tumor destruction and leading to a sustained antitumor response." @default.
• W2017013928 created "2016-06-24" @default.
• W2017013928 creator A5034771130 @default.
• W2017013928 creator A5037744441 @default.
• W2017013928 creator A5041017692 @default.
• W2017013928 creator A5046709088 @default.
• W2017013928 creator A5048310212 @default.
• W2017013928 creator A5066794430 @default.
• W2017013928 date "2008-05-01" @default.
• W2017013928 modified "2023-10-16" @default.
• W2017013928 title "Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice" @default.
• W2017013928 cites W1483682701 @default.
• W2017013928 cites W1493383266 @default.
• W2017013928 cites W1501518736 @default.
• W2017013928 cites W1561516029 @default.
• W2017013928 cites W1570714750 @default.
• W2017013928 cites W1594509286 @default.
• W2017013928 cites W1626137214 @default.
• W2017013928 cites W1630570293 @default.
• W2017013928 cites W1678167583 @default.
• W2017013928 cites W1826524642 @default.
• W2017013928 cites W1903137075 @default.
• W2017013928 cites W1966125619 @default.
• W2017013928 cites W1966603822 @default.
• W2017013928 cites W1969047155 @default.
• W2017013928 cites W1982981322 @default.
• W2017013928 cites W1983297411 @default.
• W2017013928 cites W2005055996 @default.
• W2017013928 cites W2005320381 @default.
• W2017013928 cites W2019664555 @default.
• W2017013928 cites W2023115975 @default.
• W2017013928 cites W2031778684 @default.
• W2017013928 cites W2037625112 @default.
• W2017013928 cites W2043944189 @default.
• W2017013928 cites W2048313558 @default.
• W2017013928 cites W2061432244 @default.
• W2017013928 cites W2062204245 @default.
• W2017013928 cites W2067865555 @default.
• W2017013928 cites W2072908796 @default.
• W2017013928 cites W2085851286 @default.
• W2017013928 cites W2088070169 @default.
• W2017013928 cites W2089723533 @default.
• W2017013928 cites W2094992569 @default.
• W2017013928 cites W2095548175 @default.
• W2017013928 cites W2096158777 @default.
• W2017013928 cites W2096196002 @default.
• W2017013928 cites W2103928142 @default.
• W2017013928 cites W2109896022 @default.
• W2017013928 cites W2112853593 @default.
• W2017013928 cites W2127729148 @default.
• W2017013928 cites W2133634704 @default.
• W2017013928 cites W2135484352 @default.
• W2017013928 cites W2140944306 @default.
• W2017013928 cites W2155121512 @default.
• W2017013928 cites W2160446640 @default.
• W2017013928 cites W2166891849 @default.
• W2017013928 cites W2170640588 @default.
• W2017013928 doi "https://doi.org/10.1172/jci33201" @default.
• W2017013928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2289791" @default.
• W2017013928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18398504" @default.
• W2017013928 hasPublicationYear "2008" @default.
• W2017013928 type Work @default.
• W2017013928 sameAs 2017013928 @default.
• W2017013928 citedByCount "52" @default.
• W2017013928 countsByYear W20170139282012 @default.
• W2017013928 countsByYear W20170139282013 @default.
• W2017013928 countsByYear W20170139282014 @default.
• W2017013928 countsByYear W20170139282015 @default.
• W2017013928 countsByYear W20170139282016 @default.
• W2017013928 countsByYear W20170139282017 @default.
• W2017013928 countsByYear W20170139282018 @default.
• W2017013928 countsByYear W20170139282019 @default.
• W2017013928 countsByYear W20170139282020 @default.
• W2017013928 countsByYear W20170139282022 @default.
• W2017013928 countsByYear W20170139282023 @default.
• W2017013928 crossrefType "journal-article" @default.
• W2017013928 hasAuthorship W2017013928A5034771130 @default.
• W2017013928 hasAuthorship W2017013928A5037744441 @default.
• W2017013928 hasAuthorship W2017013928A5041017692 @default.
• W2017013928 hasAuthorship W2017013928A5046709088 @default.
• W2017013928 hasAuthorship W2017013928A5048310212 @default.
• W2017013928 hasAuthorship W2017013928A5066794430 @default.
• W2017013928 hasBestOaLocation W20170139281 @default.
• W2017013928 hasConcept C151872237 @default.
• W2017013928 hasConcept C159654299 @default.
• W2017013928 hasConcept C18903297 @default.
• W2017013928 hasConcept C203014093 @default.
• W2017013928 hasConcept C2777701055 @default.
• W2017013928 hasConcept C502942594 @default.
• W2017013928 hasConcept C71924100 @default.
• W2017013928 hasConcept C86803240 @default.
• W2017013928 hasConcept C8891405 @default.
• W2017013928 hasConceptScore W2017013928C151872237 @default.
• W2017013928 hasConceptScore W2017013928C159654299 @default.
• W2017013928 hasConceptScore W2017013928C18903297 @default.
• W2017013928 hasConceptScore W2017013928C203014093 @default.
• W2017013928 hasConceptScore W2017013928C2777701055 @default.
• W2017013928 hasConceptScore W2017013928C502942594 @default.

• next